نتائج البحث

Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma.

• Authors : Watanabe, Eri¹ (AUTHOR); Yokoi, Akira^1,2 (AUTHOR) ‐u.ac.jp; Yoshida, Kosuke^1,2 (AUTHOR)

• Source: Cancer Medicine. Feb2023, Vol. 12 Issue 4, p4543-4556. 14p.

تفاصيل العنوان

A randomized, double‐blind, phase II study of oral histone deacetylase inhibitor resminostat plus S‐1 versus placebo plus S‐1 in biliary tract cancers previously treated with gemcitabine plus platinum‐based chemotherapy.

• Authors : Ueno, Makoto¹ (AUTHOR) ; Morizane, Chigusa² (AUTHOR); Furukawa, Masayuki³ (AUTHOR)

• Source: Cancer Medicine. Mar2021, Vol. 10 Issue 6, p2088-2099. 12p.

تفاصيل العنوان

Chidamide plus R‐GDP for relapsed/refractory diffuse large B‐cell lymphoma in patients ineligible for autologous transplantation: A prospective, single‐arm, phase II study.

• Authors : Chen, Guang‐Liang^1,2 (AUTHOR); Xue, Kai^1,2,3 (AUTHOR); Zhang, Qunling^1,2 (AUTHOR)

• Source: Cancer Medicine. Aug2024, Vol. 13 Issue 16, p1-9. 9p.

تفاصيل العنوان

Drug library screening identifies histone deacetylase inhibition as a novel therapeutic strategy for choriocarcinoma

• Authors : Eri Watanabe; Akira Yokoi; Kosuke Yoshida

Subjects: choriocarcinoma; drug repositioning; ferroptosis

• Source: Cancer Medicine, Vol 12, Iss 4, Pp 4543-4556 (2023)

تفاصيل العنوان

A randomized, double‐blind, phase II study of oral histone deacetylase inhibitor resminostat plus S‐1 versus placebo plus S‐1 in biliary tract cancers previously treated with gemcitabine plus platinum‐based chemotherapy

• Authors : Makoto Ueno; Chigusa Morizane; Masayuki Furukawa

Subjects: biliary tract cancers; histone deacetylase inhibitor; resminostat plus S‐1

• Source: Cancer Medicine, Vol 10, Iss 6, Pp 2088-2099 (2021)

تفاصيل العنوان

Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.

• Authors : Jang, Samuel^1,2; Jin, Haining²; Roy, Madhuchhanda²

• Source: Cancer Medicine. Sep2017, Vol. 6 Issue 9, p2142-2152. 11p.

تفاصيل العنوان

Combining the pan-aurora kinase inhibitor AMG 900 with histone deacetylase inhibitors enhances antitumor activity in prostate cancer.

• Authors : Paller, Channing J.¹; Wissing, Michel D.^1,2,3; Mendonca, Janet¹

• Source: Cancer Medicine. Oct2014, Vol. 3 Issue 5, p1322-1335. 14p.

تفاصيل العنوان

Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancer.

• Authors : McCaw TR; Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.; Goel N

Subjects: CD8-Positive T-Lymphocytes/CD8-Positive T-Lymphocytes/CD8-Positive T-Lymphocytes/*immunology ; Histone Deacetylase 1/Histone Deacetylase 1/Histone Deacetylase 1/*antagonists & inhibitors ; Histone Deacetylase Inhibitors/Histone Deacetylase Inhibitors/Histone Deacetylase Inhibitors/*pharmacology

• Source: Cancer medicine [Cancer Med] 2021 Jan; Vol. 10 (2), pp. 709-717. Date of Electronic Publication: 2020 Dec 24.Publisher: John Wiley & Sons Ltd Country of Publication: United States NLM ID: 101595310 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

Class I histone deacetylase inhibition promotes CD8 T cell activation in ovarian cancer

• Authors : Tyler R. McCaw; Nidhi Goel; Dewey J. Brooke

Subjects: epigenetics; gynecological oncology; immunology

• Source: Cancer Medicine, Vol 10, Iss 2, Pp 709-717 (2021)

تفاصيل العنوان

Targeting MTA1/ HIF-1 α signaling by pterostilbene in combination with histone deacetylase inhibitor attenuates prostate cancer progression.

• Authors : Butt, Nasir A.^1,2; Kumar, Avinash^1,3; Dhar, Swati^1,4

• Source: Cancer Medicine. Nov2017, Vol. 6 Issue 11, p2673-2685. 13p.

تفاصيل العنوان